Saad Usmani, Michał Mielnik, Aránzazu Alonso Alonso, Al-Ola Abdallah, Mamta Garg, Wojciech Janowski, Youngil Koh, Chang-Ki Min, Enrique Ocio, Hang Quach, Karthik Ramasamy, Albert Oriol, Paula Rodriguez-Otero, Ricarda Garcia Sanchez, Irwindeep Sandhu, Katja Weisel, Chris Brawley, Miguel Murillo, Fernando Carreño, Jacqueline Egger, Morrys Kaisermann, Marek Hus. "Belantamab mafodotin (belamaf) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for patients (pts) with transplant-ineligible (TI) newly diagnosed multiple myeloma (NDMM): A focus on treatment efficacy and management/resolution of ocular events in the Phase 1 dreamm-9 study." Blood (2025). https://doi.org/10.1182/blood-2025-5840